| Product Code: ETC9970969 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Multiplex Molecular Diagnosis Technology Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Multiplex Molecular Diagnosis Technology Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Multiplex Molecular Diagnosis Technology Market - Industry Life Cycle |
3.4 United States (US) Multiplex Molecular Diagnosis Technology Market - Porter's Five Forces |
3.5 United States (US) Multiplex Molecular Diagnosis Technology Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United States (US) Multiplex Molecular Diagnosis Technology Market Revenues & Volume Share, By Method, 2021 & 2031F |
4 United States (US) Multiplex Molecular Diagnosis Technology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in the US, driving the demand for accurate and rapid diagnostic solutions. |
4.2.2 Growing focus on personalized medicine and targeted therapies, creating a need for advanced molecular diagnostic technologies. |
4.2.3 Rising investments in healthcare infrastructure and research development activities to support innovation in molecular diagnostics. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for multiplex molecular diagnosis technologies, leading to delays in market entry. |
4.3.2 High costs associated with acquiring and implementing multiplex molecular diagnostic technologies, limiting adoption rates among healthcare facilities. |
4.3.3 Limited awareness and technical expertise among healthcare professionals regarding the benefits and applications of multiplex molecular diagnostics. |
5 United States (US) Multiplex Molecular Diagnosis Technology Market Trends |
6 United States (US) Multiplex Molecular Diagnosis Technology Market, By Types |
6.1 United States (US) Multiplex Molecular Diagnosis Technology Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Multiplex Molecular Diagnosis Technology Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United States (US) Multiplex Molecular Diagnosis Technology Market Revenues & Volume, By Analyzers, 2021- 2031F |
6.1.4 United States (US) Multiplex Molecular Diagnosis Technology Market Revenues & Volume, By Software, 2021- 2031F |
6.1.5 United States (US) Multiplex Molecular Diagnosis Technology Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.6 United States (US) Multiplex Molecular Diagnosis Technology Market Revenues & Volume, By Centrifuge, 2021- 2031F |
6.1.7 United States (US) Multiplex Molecular Diagnosis Technology Market Revenues & Volume, By Counting Chambers, 2021- 2031F |
6.1.8 United States (US) Multiplex Molecular Diagnosis Technology Market Revenues & Volume, By Incubators, 2021- 2031F |
6.2 United States (US) Multiplex Molecular Diagnosis Technology Market, By Method |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Multiplex Molecular Diagnosis Technology Market Revenues & Volume, By Real-time PCR, 2021- 2031F |
6.2.3 United States (US) Multiplex Molecular Diagnosis Technology Market Revenues & Volume, By Nested PCR with Melt Curve Analysis, 2021- 2031F |
6.2.4 United States (US) Multiplex Molecular Diagnosis Technology Market Revenues & Volume, By PCR with Low Density Microarray, 2021- 2031F |
6.2.5 United States (US) Multiplex Molecular Diagnosis Technology Market Revenues & Volume, By PCR with Liquid Phase Bead Array, 2021- 2031F |
6.2.6 United States (US) Multiplex Molecular Diagnosis Technology Market Revenues & Volume, By PCR with Electrochemical Detection, 2021- 2031F |
7 United States (US) Multiplex Molecular Diagnosis Technology Market Import-Export Trade Statistics |
7.1 United States (US) Multiplex Molecular Diagnosis Technology Market Export to Major Countries |
7.2 United States (US) Multiplex Molecular Diagnosis Technology Market Imports from Major Countries |
8 United States (US) Multiplex Molecular Diagnosis Technology Market Key Performance Indicators |
8.1 Adoption rate of multiplex molecular diagnosis technologies in healthcare facilities. |
8.2 Number of research studies and publications utilizing multiplex molecular diagnostic technologies. |
8.3 Rate of reimbursement for multiplex molecular diagnostic tests by healthcare payers. |
8.4 Average turnaround time for test results using multiplex molecular diagnostic technologies. |
8.5 Number of partnerships and collaborations between technology providers and healthcare institutions to enhance market penetration. |
9 United States (US) Multiplex Molecular Diagnosis Technology Market - Opportunity Assessment |
9.1 United States (US) Multiplex Molecular Diagnosis Technology Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United States (US) Multiplex Molecular Diagnosis Technology Market Opportunity Assessment, By Method, 2021 & 2031F |
10 United States (US) Multiplex Molecular Diagnosis Technology Market - Competitive Landscape |
10.1 United States (US) Multiplex Molecular Diagnosis Technology Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Multiplex Molecular Diagnosis Technology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here